In Brief
Refine Search
Pharmaceutical
Vaxelis (diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, Hemophilus b conjugate and hepatitis B vaccine), developed as part of a partnership between Sanofi Pasteur, the global vaccines business unit of Sanofi, and Merck & Co, is now available in the USA. 1 June 2021
Biotechnology
The European Medicines Agency’s human medicines committee (CHMP) has recommended granting an extension of indication for the COVID-19 vaccine Comirnaty to include use in children aged 12 to 15. 28 May 2021
Pharmaceutical
The European Medicines Agency’s COVID-19 taskforce (COVID-EFT) is advising healthcare professionals that there is currently insufficient evidence that inhaled corticosteroids are beneficial for people with COVID-19. 28 May 2021
Pharmaceutical
The European Commission (EC) has approved the marketing authorization for Efmody (hydrocortisone modified-release hard capsules – development name Chronocort). 28 May 2021
Biotechnology
Ireland's ONK Therapeutics has gained exclusive global rights to innovative immuno-oncology technology developed at Australia’s Walter and Eliza Hall Institute of Medical Research (WEHI). 27 May 2021
Biotechnology
The government of Chinese city Shanghai will heavily subsidize local biotechs' innovation and global expansion. 27 May 2021
Pharmaceutical
Shares of UK developer of inhaled therapies developer Vectura (LSE: VEC) closed up 34% at 163.20 pence today, after the company agreed on a £958 million takeover by private equity firm Carlyle Group. 26 May 2021
Biotechnology
The US Food and Drug Administration issued a final guidance, Bispecific Antibody Development Programs. 25 May 2021
Biotechnology
The US Food and Drug Administration has accepted for priority review a New Drug Application (NDA) for maribavir, submitted by Japanese pharma major Takeda Pharmaceuticals, for the treatment of cytomegalovirus (CMV) infection in those that are refractory with or without resistance (R/R), in solid organ transplant (SOT) or hematopoietic cell transplant (HCT) recipients. 23 May 2021
Pharmaceutical
Danish diabetes care giant Novo Nordisk today announced that it has established a Euro Medium Term Note (EMTN) program. 21 May 2021
Biotechnology
Full results have been presented from the investigator-sponsored SAVE-MORE study of anakinra in COVID-19 pneumonia by Swedish Orphan Biovitrum, the company more commonly-known as Sobi, and the Hellenic Institute for the Study of Sepsis. 20 May 2021
Pharmaceutical
Cambridge, UK-based Arecor has signed a formulation study partnership with Eli Lilly, based around its proprietary formulation technology platform Arestat. 20 May 2021
Biotechnology
HRA Pharma Rare Diseases, an affiliate of privately-held French healthcare company HRA Pharma, has revealed data from the six-month extension of PROMPT, the first ever prospective study designed to evaluate metyrapone long-term efficacy and tolerability in endogenous Cushing’s syndrome. 20 May 2021
Pharmaceutical
The world’s biggest vaccine maker, the Serum Institute of India (SII), plans to extend its halt on COVID-19 vaccine exports until the end of the year, according to local media reports and the UK’s Financial Times. 19 May 2021
Biotechnology
National Resilience, a CDMO focused on advanced therapies, has received a CA$199 million ($164 million) investment from the Canadian government. 19 May 2021
Biotechnology
India’s Panacea Biotech has sued Sanofi from launching a pediatric vaccine that protects against six diseases. 18 May 2021
Biotechnology
The US subsidiary of Taiwan-based PharmaEssentia has resubmitted its Biologics License Application (BLA) to the US Food and Drug Administration (FDA), seeking approval for ropeginterferon alfa-2b-njft for the treatment of polycythemia vera (PV), a rare blood cancer. 15 May 2021
Pharmaceutical
Mitsubishi Tanabe Pharma Corporation has discontinued its development of the ulcerative colitis (UC) candidate MT-5745/STNM01 (carbohydrate sulfotransferase). 14 May 2021
Biotechnology
New York-based drug discovery firm Bantam Pharmaceutical has appointed Michael Stocum as president and chief executive, replacing founding CEO Mike Luther, who will remain as an advisor to the executive team. 14 May 2021
Pharmaceutical
The US Food and Drug Administration has approved Zynrelef (bupivacaine/meloxicam) for use in adults to reduce pain for up to three days after removal of bunions, groin hernia repair, and total knee replacement. 13 May 2021
Biotechnology
Japanese drugmaker Takeda has launched Fruzaqla (fruquintinib) in its home country. 22 November 2024
Biotechnology
Chinese biopharma CStone Pharmaceuticals has announced a strategic commercial collaboration with Pharmalink Store, a prominent pharmaceutical company based in the United Arab Emirates (UAE). 22 November 2024
Biotechnology
Zhongshan-based biopharma company Akeso will await the verdict of the Chinese medicines regulator on a penpulimab-based combo therapy. 22 November 2024
Biotechnology
US biotech Paragon Therapeutics yesterday revealed that biotech industry veteran Susanna High has been appointed as chief executive (CEO). In this newly-created role, Ms High will lead the team’s continued efforts to propel the development of a pipeline of transformative therapies and accelerate their potential impact. 22 November 2024
Pharmaceutical
Shanghai-based Zai Lab and New York’s Pfizer are to work together on the commercialization of Xacduro (sulbactam-durlobactam) in China. 22 November 2024
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
Biotechnology
California-based venture capital firm Versant Ventures yesterday announced the launch of Pep2Tango Therapeutics, a start-up focused on innovative, next-generation weight loss therapies. Proceeds from the significant, undisclosed round will support development of the company’s novel unimolecular tetra-receptor agonist peptides to treat obesity and related conditions. 22 November 2024
Biotechnology
Hong Kong-based Sino Biopharm has signed an equity investment and strategic collaboration agreement with LaNova Medicines, advancing its oncology focus. 22 November 2024
Biotechnology
British pharma major AstraZeneca is facing challenges in its bid to secure full approval for its anticoagulant reversal therapy, Andexxa (andexanet alfa), in the USA. 22 November 2024
Biotechnology
Colorado, USA-based biotech Enveda Biosciences, which is using AI to translate nature into new medicines, has announced an oversubscribed $130 million Series C funding round led by Kinnevik and FPV. 22 November 2024
Biotechnology
Privately-held US biotech Alloy Therapeutics has announced a strategic collaboration and license agreement with Takeda Pharmaceutical. 21 November 2024
Pharmaceutical
Japanese drugmaker Eisai has announced that the amyotrophic lateral sclerosis (ALS) treatment Rozebalamin for Injection (mecobalamin) has been launched in Japan as a treatment for slowing progression of functional impairment in amyotrophic lateral sclerosis. 21 November 2024
Pharmaceutical
Germany's Merck has spent more than 25 years researching and developing solutions for advancing multiple sclerosis (MS) care. 21 November 2024
Biotechnology
San Diego-based Cidara Therapeutics, a biotech using its proprietary Cloudbreak platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, has entered into a securities purchase agreement with certain investors to raise up to around $105 million. 21 November 2024
Pharmaceutical
Swiss pharma giant Novartis today announced an upgrade to its mid-term guidance, in advance of its Meet Novartis Management event for investors and analysts in London. 21 November 2024
Biotechnology
The US Food and Drug Administration (FDA) has granted accelerated approval of Ziihera (zanidatamab-hrii) 50mg/mL for injection for intravenous use, say the drug’s developer, Jazz Pharmaceuticals. 21 November 2024
Biotechnology
Eli Lilly is not resting on its laurels when it comes to the fast-growing field of obesity treatments, an area in which it is already a leader. 21 November 2024
Biotechnology
Aizen Therapeutics, an AI-driven biotech headquartered in San Diego, has officially launched from stealth mode, introducing its drug discovery platform, DaX. 21 November 2024
Biotechnology
San Diego-based Valora Therapeutics, a biotech that boasts of having a novel approach to immunotherapy, has announced the successful closing of a $30 million seed funding round. 21 November 2024
Biotechnology
Astellas Pharma has been hit by bad news from the US Food and Drug Administration, which will not currently approve the firm’s request to supplement the label for Izervay (avacincaptad pegol). 21 November 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze